CarMax (KMX): Just got recommended by a top Morningsta...

Just got recommended by a top Morningstar fund

Trueheart · 2018-03-15T19:10:09.2600000Z

Just got recommended by a top Morningstar fund head. May be worth investigating. Trueheart

Play Episode

3min

Proactive - Interviews for investors

Kodal Minerals nears completion at Bougouni Lithium project, prepares for exports

Kodal Minerals PLC (AIM:KOD) CEO Bernard Aylward takes Proactive's Stephen Gunnion through the company's latest update on its Bougouni lithium project in Mali, where construction is nearly complete and preparations for export are underway. Aylward shared that the optimisation and ramp-up phase of the processing plant has been going well, with over 11,000 tonnes of lithium concentrate already stockpiled and ready for export. "We've been making some adjustments as we go through this process and some improvements to the feed into the crusher... achieving a good product," he said. He noted that the company expects to reach nameplate capacity within the next couple of months, pending a final review and approval by the construction team. Kodal is also progressing steadily on the mining front, with a good run-of-mine (ROM) stockpile in place. The interview highlighted that the mining license transfer process is still ongoing, though Kodal has completed all compliance steps and is now awaiting sign-off from the Committee of Ministers and the President of Mali. Once this is finalised, the company will move forward with export permits and begin shipping product. Visit Proactive’s YouTube channel for more company updates. Don’t forget to like this video, subscribe, and turn on notifications to stay up to date. #KodalMinerals #Lithium #BougouniProject #MiningNews #BatteryMetals #MaliMining #ResourceDevelopment #LithiumProduction #MineralExploration #CriticalMinerals

Proactive - Interviews for investors

Team Internet CEO highlights strategic momentum across Domains, Comparison, and Search divisions

Team Internet CEO Michael Riedl joined Steve Darling from Proactive’s OTC studio in New York City to update the company’s strategic progress across its three core business segments: domains, comparison, and search. Each division, Riedl explained, is navigating a distinct phase of growth, underpinned by a clear long-term vision and strong operational execution. In the domains division, Team Internet continues to serve as a trusted partner to some of the world’s leading web hosting and cybersecurity providers. The company’s expertise in securing and managing global online identities remains a foundational strength, supporting businesses as they establish and protect their digital presence in an increasingly interconnected world. The comparison segment has seen exceptional performance in 2024, with over 40% organic growth year-to-date. Profitability in this division has also surged, with profits increasing by an impressive 75%. This momentum reflects strong consumer demand, effective execution, and the scalability of Team Internet’s comparison platforms. Looking ahead, the company has set its sights on international expansion, with plans to take its successful comparison model beyond Germany into new high-potential markets. Riedl also shared insights into the ongoing transformation of the search business, which is transitioning from the legacy AdSense for Domains model to a more advanced offering known as "Related Search on Content." While the shift presents transitional challenges, the new model is already gaining traction. “Even though this transition gives us some challenges, as demonstrated by our recent reforecast, this business is really going very well,” Riedl noted. He highlighted that the search division is now scaling rapidly, adding nearly $10 million in annual recurring revenue (ARR) every week—a clear signal of its growth potential and strategic importance. The U.S. market continues to play a central role in Team Internet’s overall strategy, currently

Proactive - Interviews for investors

Nextech3D.ai signs LOI to sell majority stake in Toggle3D.ai securing strategic non-dilutive capital

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce a pivotal strategic development for the company. Nextech3D.ai has entered into a Letter of Intent to sell up to an 80% equity interest in its spin-out subsidiary, Toggle3D.ai, to TQG Technologies. The proposed transaction not only transitions Toggle3D.ai into its next phase of evolution under new majority ownership, but also provides Nextech3D.ai with a non-dilutive capital infusion of CAD $610,000, strengthening the company’s balance sheet and strategic flexibility without impacting existing shareholder equity. Gappelberg explained that the transaction will be structured in three tranche wuth TQG Technologies acquireing 11 million shares of Toggle3D.ai for CAD $610,000 in cash. Contingent on the closing of TQG’s capital raise, an additional 5 million shares will be purchased for CAD $276,000. The final stage will complete the 80% acquisition through a combination of share purchases and the vending-in of TQG’s strategic assets into Toggle3D.ai. As part of the agreement framework, a non-refundable deposit of CAD $177,000 will be paid by TQG upon the finalization of the deal’s structure by its management. Further milestone-based payments are scheduled to be completed by August 2025. Additionally, Nextech3D.ai stands to receive a performance-based bonus of CAD $710,000 if TQG successfully closes a financing round of at least USD $5 million by that time. The two companies plan to issue a joint public announcement upon the execution of the definitive agreement and will coordinate a co-branded PR campaign to spotlight Toggle3D.ai’s new strategic direction and business roadmap under TQG’s leadership. #nextech3d.al #otcqx #nexcf #cse #ntar #EvanGappelberg #ARway #AugmentedReality #SpatialMapping #IndoorNavigation #MapDynamics #EventTech #TradeShowSolutions #TechStocks #ARRevenueGrowth #3DTechnology #ProactiveInvestors #toggle3d TQGtechnologies

Proactive - Interviews for investors

Ananda Develops U.S. presence as lead drug advances to Phase 1 clinical study

Ananda Pharma CEO Melissa Sturgess joined Steve Darling from Proactive to announce the company’s shares have begun trading on the OTCQB market in the United States, a strategic move that expands Ananda’s visibility and access to U.S. investors. The UK-based biopharmaceutical company is focused on developing regulatory-approved cannabinoid medicines for complex and chronic medical conditions. Sturgess emphasized the significance of entering the U.S. market, not only from a capital markets perspective but also as a key future territory for Ananda’s clinical and commercial ambitions. She also highlighted recent progress in the company’s clinical development pipeline, particularly around its lead investigational drug candidate, MRX1. Ananda recently received approval from the Alfred Hospital Human Research Ethics Committee in Australia to initiate a Phase 1 pharmacokinetic study of MRX1. The study will evaluate the safety, tolerability, and pharmacokinetics of two dose levels of the CBD-based drug in a cohort of 20 healthy adult volunteers—10 biological males and 10 biological females—to address known sex differences in CBD metabolism. MRX1 is a high-purity, pharmaceutical-grade cannabidiol (CBD) formulation developed under rigorous quality standards to ensure consistency, safety, and clinical reliability. It is intended for the treatment of chronic inflammatory pain conditions, where current treatment options often fall short in efficacy or come with undesirable side effects. Sturgess noted that this ethics approval marks a critical milestone in the company’s journey toward regulatory approval and commercial readiness. The trial is expected to generate key safety and dosing data to support future Phase 2 studies targeting patients with unmet needs in chronic pain management. #proactiveinvestors #aqse #ana #cbd #otcqb #MRX1 #CBDDrugDevelopment #CannabinoidTherapy #ClinicalTrials #FDAApproval #PharmaNews #BiotechStocks #OTCQB #GWPharma #CBDMedicine #ChronicPainTreat

Followers	88
Posts	20653
Boards Moderated	0
Alias Born	06/16/2006

Volume:	2,270,752
Day Range:	63.63 - 64.77
Bid:
Ask:
Last Trade Time:	7:52:16 PM EDT
Total Trades:	33,893

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

KMX Detailed Quote

Recent KMX News

More KMX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent KMX News

Go Ad-Free